Home0K4 • FRA
add
Akero Therapeutics Inc
Previous close
€24.10
Day range
€22.08 - €22.08
Year range
€16.50 - €32.78
Market cap
1.53B USD
Avg Volume
23.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 81.70M | 75.27% |
Net income | -72.70M | -83.33% |
Net profit margin | — | — |
Earnings per share | -1.05 | -47.89% |
EBITDA | -81.70M | -75.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 717.25M | 29.30% |
Total assets | 817.55M | 28.68% |
Total liabilities | 79.22M | 51.78% |
Total equity | 738.32M | — |
Shares outstanding | 69.80M | — |
Price to book | 2.27 | — |
Return on assets | -24.28% | — |
Return on capital | -25.40% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -72.70M | -83.33% |
Cash from operations | -70.42M | -41.64% |
Cash from investing | 73.07M | 158.13% |
Cash from financing | 3.07M | 280.52% |
Net change in cash | 5.71M | 103.27% |
Free cash flow | -45.93M | -25.63% |
About
Founded
2017
Headquarters
Website
Employees
60
